Whiles sNGAL showed superiority and is recommended, NLR showed no significant group difference and poor, non-significant discrimination, indicating it is not a reliable standalone marker of diabetic nephropathy in this study.
Ayirebi et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: